# Glucocorticoid Treatment for Social Phobia

> **NCT01574014** · PHASE2 · TERMINATED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 66 (actual)

## Conditions studied

- Phobic Disorders
- Phobias

## Interventions

- **BEHAVIORAL:** CBGT
- **DRUG:** Hydrocortisone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01574014
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07
- **Primary completion:** 2012-03
- **Final completion:** 2012-04
- **Target enrollment:** 66 (ACTUAL)
- **Why stopped:** Recruiting problems
- **Last updated:** 2012-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01574014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01574014, "Glucocorticoid Treatment for Social Phobia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01574014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
